BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

871 related articles for article (PubMed ID: 26160308)

  • 1. Supramolecular nanoscale assemblies for cancer diagnosis and therapy.
    Coelho SC; Pereira MC; Juzeniene A; Juzenas P; Coelho MAN
    J Control Release; 2015 Sep; 213():152-167. PubMed ID: 26160308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
    Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
    Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting.
    Huynh NT; Roger E; Lautram N; Benoît JP; Passirani C
    Nanomedicine (Lond); 2010 Nov; 5(9):1415-33. PubMed ID: 21128723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymeric nanoparticles for cancer therapy.
    Parveen S; Sahoo SK
    J Drug Target; 2008 Feb; 16(2):108-23. PubMed ID: 18274932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
    Bhunchu S; Rojsitthisak P
    Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Cancer Drug Delivery Using Carbohydrate-Based Polymers.
    Ranjbari J; Mokhtarzadeh A; Alibakhshi A; Tabarzad M; Hejazi M; Ramezani M
    Curr Pharm Des; 2018 Feb; 23(39):6019-6032. PubMed ID: 28482782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle approaches to combating drug resistance.
    Moon JH; Moxley JW; Zhang P; Cui H
    Future Med Chem; 2015 Aug; 7(12):1503-10. PubMed ID: 26334205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
    Zhang J; Tang H; Liu Z; Chen B
    Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer chemotherapy with lipid-based nanocarriers.
    Liu D; Zhang N
    Crit Rev Ther Drug Carrier Syst; 2010; 27(5):371-417. PubMed ID: 21083528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing the Delivery of Chemotherapeutics: Role of Biodegradable Polymeric Nanoparticles.
    Ahlawat J; Henriquez G; Narayan M
    Molecules; 2018 Aug; 23(9):. PubMed ID: 30150595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug nanocarriers and functional nanoparticles: applications in cancer therapy.
    Thierry B
    Curr Drug Deliv; 2009 Aug; 6(4):391-403. PubMed ID: 19534706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers for the treatment of glioblastoma multiforme: Current state-of-the-art.
    Karim R; Palazzo C; Evrard B; Piel G
    J Control Release; 2016 Apr; 227():23-37. PubMed ID: 26892752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
    Olov N; Bagheri-Khoulenjani S; Mirzadeh H
    J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polymer nanoparticles for the delivery of anticancer drug].
    Nicolas J; Couvreur P
    Med Sci (Paris); 2017 Jan; 33(1):11-17. PubMed ID: 28120750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
    Lakkakula JR; Maçedo Krause RW
    Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nanotechnologies for designing new medicines].
    Couvreur P
    Biol Aujourdhui; 2012; 206(4):237-48. PubMed ID: 23419251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
    Tanbour R; Martins AM; Pitt WG; Husseini GA
    Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.